3-37025608-ATTTTTTTTT-ATTTTTT
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_000249.4(MLH1):c.1039-10_1039-8delTTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00241 in 306,194 control chromosomes in the GnomAD database, including 4 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00010 ( 0 hom., cov: 0)
Exomes 𝑓: 0.0028 ( 4 hom. )
Consequence
MLH1
NM_000249.4 splice_region, intron
NM_000249.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.431
Publications
1 publications found
Genes affected
MLH1 (HGNC:7127): (mutL homolog 1) The protein encoded by this gene can heterodimerize with mismatch repair endonuclease PMS2 to form MutL alpha, part of the DNA mismatch repair system. When MutL alpha is bound by MutS beta and some accessory proteins, the PMS2 subunit of MutL alpha introduces a single-strand break near DNA mismatches, providing an entry point for exonuclease degradation. The encoded protein is also involved in DNA damage signaling and can heterodimerize with DNA mismatch repair protein MLH3 to form MutL gamma, which is involved in meiosis. This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). [provided by RefSeq, Aug 2017]
MLH1 Gene-Disease associations (from GenCC):
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet
- Lynch syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
- Muir-Torre syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Orphanet
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
- Lynch syndrome 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- ovarian cancerInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 3-37025608-ATTT-A is Benign according to our data. Variant chr3-37025608-ATTT-A is described in ClinVar as Likely_benign. ClinVar VariationId is 1697940.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAdExome4 allele frequency = 0.00285 (734/257920) while in subpopulation AFR AF = 0.00987 (33/3342). AF 95% confidence interval is 0.00723. There are 4 homozygotes in GnomAdExome4. There are 346 alleles in the male GnomAdExome4 subpopulation. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 4 AD,AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000104 AC: 5AN: 48286Hom.: 0 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
5
AN:
48286
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00559 AC: 78AN: 13956 AF XY: 0.00369 show subpopulations
GnomAD2 exomes
AF:
AC:
78
AN:
13956
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00285 AC: 734AN: 257920Hom.: 4 AF XY: 0.00270 AC XY: 346AN XY: 128056 show subpopulations
GnomAD4 exome
AF:
AC:
734
AN:
257920
Hom.:
AF XY:
AC XY:
346
AN XY:
128056
show subpopulations
African (AFR)
AF:
AC:
33
AN:
3342
American (AMR)
AF:
AC:
5
AN:
1266
Ashkenazi Jewish (ASJ)
AF:
AC:
8
AN:
2080
East Asian (EAS)
AF:
AC:
11
AN:
3034
South Asian (SAS)
AF:
AC:
23
AN:
5270
European-Finnish (FIN)
AF:
AC:
5
AN:
1212
Middle Eastern (MID)
AF:
AC:
1
AN:
526
European-Non Finnish (NFE)
AF:
AC:
612
AN:
232478
Other (OTH)
AF:
AC:
36
AN:
8712
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.402
Heterozygous variant carriers
0
36
72
107
143
179
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000104 AC: 5AN: 48274Hom.: 0 Cov.: 0 AF XY: 0.0000930 AC XY: 2AN XY: 21494 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome
AF:
AC:
5
AN:
48274
Hom.:
Cov.:
0
AF XY:
AC XY:
2
AN XY:
21494
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
4
AN:
12040
American (AMR)
AF:
AC:
0
AN:
3254
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
1520
East Asian (EAS)
AF:
AC:
0
AN:
2064
South Asian (SAS)
AF:
AC:
0
AN:
1336
European-Finnish (FIN)
AF:
AC:
0
AN:
876
Middle Eastern (MID)
AF:
AC:
0
AN:
44
European-Non Finnish (NFE)
AF:
AC:
1
AN:
26192
Other (OTH)
AF:
AC:
0
AN:
606
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.00711407), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
La Branchor
BranchPoint Hunter
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.